Stem Cells Can Revive Insulin Production in Type 1 Diabetes, Trials Show

Early trials suggest stem cell-derived beta cells can produce insulin in people with Type 1 diabetes.

Some patients have gone months or longer without insulin injections after transplantation.

If the approach proves safe and durable, it could treat the root cause rather than just manage blood sugar.

Researchers still need to confirm long-term effectiveness and address immune rejection risks.